Global Injectable Drug Delivery Market Analysis and Forecast Report 2030
$5000 – $10000
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) – Forecast to 2021
Description
Global Injectable Drug Delivery Market Analysis and Forecast Report 2030
Market Overview
CRI has released a report titled Injectable Drug Delivery Market – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031. The market is anticipated to reach USD 362.4 billion in 2020 to USD 624.5 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 11.5% . According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Injectable Drug Delivery Market Market: Key Players
Becton,
Dickinson and Company (U.S.),
Pfizer Inc. (U.S.),
Teva Pharmaceuticals Industries Ltd. (Israel),
Eli Lilly and Company (U.S.),
Baxter International, Inc. (U.S.),
Schott AG (Germany),
Gerresheimer (Germany),
Ypsomed (Switzerland), and
B. Braun Melsungen (Germany).
Segmentation
Injectable Drug Delivery Market, by Type
Devices
Formulations
Injectable Drug Delivery Market, by Formulation Packaging
Ampules
Vials
Cartridges
Bottles
Injectable Drug Delivery Market, by Therapeutic Application
Auto-immune diseases
Hormonal Disorders
Orphan Diseases
Oncology
Other Therapeutic Applications
Injectable Drug Delivery Market, by Usage Pattern
Curative Care
Immunization
Other Usage Pattern
Injectable Drug Delivery Market, by Site of Administration
Skin
Circulatory/Musculoskeletal
Organs
Central Nervous System
Injectable Drug Delivery Market, by Distribution Channel
Hospitals
Retail Pharmacy Stores
Injectable Drug Delivery Market, by Facility of Use
Hospitals & Clinics
Home Care Settings
Other Facilities of Use
Injectable Drug Delivery Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K
Rest of Europe (RoE)
Asia
China
India
Japan
Rest of Asia (RoA)
Rest of the World (RoW)
Injectable Drug Delivery Market Market Dynamics
Injectable Drug Delivery Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Injectable Drug Delivery Market Market growth?
Which segment accounted for the largest Injectable Drug Delivery Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in CRI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Related Reports: Global Sturge-Weber Syndrome Market Research Report – Forecast To 2023
Table of Contents
Contents
1. Executive Summary
2. Injectable Drug Delivery Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Injectable Drug Delivery Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Injectable Drug Delivery Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Injectable Drug Delivery Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Becton,
Dickinson and Company (U.S.),
Pfizer Inc. (U.S.),
Teva Pharmaceuticals Industries Ltd. (Israel),
Eli Lilly and Company (U.S.),
Baxter International, Inc. (U.S.),
Schott AG (Germany),
Gerresheimer (Germany),
Ypsomed (Switzerland), and
B. Braun Melsungen (Germany).
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Reviews
There are no reviews yet.